QQQ $ 442.84 $ -0.57 (-0.13 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ -0.23 (-0.04 %)
TLT $ 90.36 $ 0.25 (0.28 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 0.1456
-- x --
-- x --
-- - --
$ 0.13 - $ 0.42
410,870
na
143.01M
$ 0.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-15-2024 02-29-2024 10-Q
2 01-16-2024 11-30-2023 10-Q
3 10-23-2023 08-31-2023 10-Q
4 09-13-2023 05-31-2023 10-K
5 04-10-2023 02-28-2023 10-Q
6 01-09-2023 11-30-2022 10-Q
7 10-11-2022 08-31-2022 10-Q
8 08-15-2022 05-31-2022 10-K
9 04-11-2022 02-28-2022 10-Q
10 01-10-2022 11-30-2021 10-Q
11 10-12-2021 08-31-2021 10-Q
12 07-30-2021 05-31-2021 10-K
13 04-14-2021 02-28-2021 10-Q
14 01-08-2021 11-30-2020 10-Q
15 10-09-2020 08-31-2020 10-Q
16 08-14-2020 05-31-2020 10-K
17 04-09-2020 02-29-2020 10-Q
18 01-09-2020 11-30-2019 10-Q
19 10-08-2019 08-31-2019 10-Q
20 08-14-2019 05-31-2019 10-K
21 04-09-2019 02-28-2019 10-Q
22 01-09-2019 11-30-2018 10-Q
23 10-09-2018 08-31-2018 10-Q
24 07-27-2018 05-31-2018 10-K
25 04-09-2018 02-28-2018 10-Q
26 01-08-2018 11-30-2017 10-Q
27 10-10-2017 08-31-2017 10-Q
28 07-20-2017 05-31-2017 10-K
29 04-13-2017 02-28-2017 10-Q
30 01-13-2017 11-30-2016 10-Q
31 10-12-2016 08-31-2016 10-Q
32 07-19-2016 05-31-2016 10-K
33 04-13-2016 02-29-2016 10-Q
34 01-11-2016 11-30-2015 10-Q
35 10-09-2015 08-31-2015 10-Q
36 07-10-2015 05-31-2015 10-K
37 04-10-2015 02-28-2015 10-Q
38 01-12-2015 11-30-2014 10-Q
39 10-10-2014 08-31-2014 10-Q
40 07-10-2014 05-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 these-2-under-the-radar-stocks-traded-more-than-1b-each-last-month

The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks th...

 the-daily-biotech-pulse-amylyx-announces-negative-adcom-vote-clovis-jumps-on-ovarian-cancer-data-masimo-warns-of-q1-shortfall

Here's a roundup of top developments in the biotech space over the last 24 hours:

 cytodyn-highlights-research-paper-leronlimab-pro-140-activity-against-4-class-drug-resistant-hiv-1-from-heavily-treatment-experienced-subjects-in-sciencedirect

CytoDyn previously hit a primary endpoint in a pivotal Phase 3 HIV trial with some HTE patients; over 20 patients remain in an ...

 the-daily-biotech-pulse-moderna-invests-in-africa-amgen-announces-neuroscience-rd-collaboration-decision-day-for-chemocentryx-biophytis-to-restate-results

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 the-daily-biotech-pulse-apellis-sinks-on-data-endo-shines-on-opioid-litigation-settlement-t2-biosystems-soars-on-mutant-detection-ability-of-covid-test

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 the-daily-biotech-pulse-spero-secures-niaid-funding-glaxosmithkline-releases-covid-19-data-biontech-gets-new-cfo

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 why-auris-medical-cytodyn-and-prometheus-shares-are-moving-today

Auris Medical Holding Ltd.

 fda-decisions-for-pfizer-eli-lilly-and-bluebird-bio-bristol-meyers-squibb-plus-new-data-and-earnings

Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market p...

 the-daily-biotech-pulse-aptinyx-jumps-on-positive-readout-cara-executes-korsuva-licensing-deal-cleveland-biolabs-rallies-on-reverse-merger

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 senior-administration-official-says-cytodyn-isnt-being-considered-for-operation-warp-speed-at-this-time

-Bloomberg

 the-daily-biotech-pulse-novavax-vaccine-deals-trevena-awaits-fda-decision-2-ipos

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 6)

 cytodyn-to-hold-conference-call-on-july-30-to-provide-updates-on-its-two-covid-19-trials

CytoDyn Inc. (OTC.QB: CYDY), ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronl...

 the-daily-biotech-pulse-mallinckrodt-gets-fda-panel-backing-regulatory-setback-for-tricida-relay-therapeutics-ipo

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 cytodyn-reports-filing-of-application-for-nasdaq-uplist

CytoDyn Inc. (OTC.QB: CYDY), ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronl...

 hc-wainwright--co-downgrades-cytodyn-to-neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades CytoDyn (OTC:CYDY) from Buy to Neutral.

 traders-had-cannabis-and-transportation-companies-on-otc-markets-in-focus-during-may

The massive rally in stocks around the globe in April and May ended up marking the best 50-day rally for stocks in history.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION